Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeatStitch was an Israeli medical device company focused on laparoscopic port-closure solutions for minimally invasive surgery. Its lead and apparently primary product was NeatClose, an automated suturing device intended for approximation and ligation of soft tissues and closure of 10 mm or larger laparoscopic port sites. The device received FDA 510(k) clearance in 2006 and was also reported to have obtained CE mark approval. NeatStitch positioned the product as a faster, simpler alternative to manual fascial closure that could reduce procedure time and lower the risk of port-site complications such as herniation. Available company-directory sources indicate the company later ceased operations, with multiple databases describing it as deadpooled or ceased operating.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NeatStitch.